Asia Pacific Superdisintegrants Market By Product Type (Natural Superdisintegrants, Synthetic Superdisintegrants (modified Starch, Crospovidone, Modified Cellulose, Ion Exchange Resins And Calcium Silicates), And Others), By Application (Capsules And Tablets), By Therapeutic Area (gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Haematological Diseases, And Inflammatory Diseases), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Asia Pacific Superdisintegrants Market By Product Type (Natural Superdisintegrants, Synthetic Superdisintegrants (modified Starch, Crospovidone, Modified Cellulose, Ion Exchange Resins And Calcium Silicates), And Others), By Application (Capsules And Tablets), By Therapeutic Area (gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Haematological Diseases, And Inflammatory Diseases), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 2869 | Pages: 140 | August 2017 | Region: Asia Pacific


The Asia Pacific Superdisintegrants Market was worth USD 54.7 million in 2016 and estimated to be growing at a CAGR of 8.92%, to reach USD 83.3 million by 2021. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.

Tablet based (Oral) drug administration is the most common way to drug delivery. Most of the common medicines are orally delivered. Excipients are the substances that make up the rest of tablet other than the medicating substance itself, it is used for long term stabilization and bulking up solid contents. One of the type of excipients are superdisintegrants which accelerate the dissociating and dissolving ability of the tablet in the presence of water for a speedy drug delivery.

The main factors driving the market are development of new superdisintegrants in pharmaceutical industry, growing population of geriatric and paediatric patients and growing generic drugs market. However, the markets growth is restricted by the declining financial investments for R&D fields. Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.

The Asia Pacific market for Superdisintegrants is segmented based on Product type, application and therapeutic area. Based on crop type – Natural and Synthetic Superdisintegrants. Synthetic Superdisintegrants are further segmented into modified starch, crospovidone, modified cellulose, ion exchange resins and calcium silicates. Based on Application – Tablets and Capsules. Based on Therapeutic Area – gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases. Based on Geographical analysis the market is separated into regions of China, India, Japan, South-Korea and Australia. China is leading the market while India is at second place. Large population and rapid medical advancements has assisted the dominance of China in the market. India is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness. The synthetic superdisintegrant market segment held the largest share of the Asia Pacific superdisintegrants market. This is mainly accounted to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets. Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.

Some of the key players dominating this market include Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.

1.Introduction                                                                  

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product Type                                                             

                                5.1.1 Introduction                                           

                                5.1.2 Natural Superdisintegrants                                              

                                5.1.3 Synthetic Superdisintegrants                                          

                                                5.1.3.1 Modified Starch                

                                                5.1.3.2 Crospovidone                    

                                                5.1.3.3 Modified Cellulose                           

                                                5.1.3.4 Ion Exchange Resins                        

                                                5.1.3.5 Calcium Silicates                

                                5.1.4 Others                                      

                                5.1.5  Y-o-Y Growth Analysis, By Product Type                                   

                                5.1.6  Market Attractiveness Analysis, By Product Type                                 

                                5.1.7  Market Share Analysis, By Product Type                                   

                5.2 Application                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Capsules                                  

                                5.2.3 Tablets                                      

                                5.2.4 Y-o-Y Growth Analysis, By Application                                         

                                5.2.5 Market Attractiveness Analysis, By Application                                       

                                5.2.6 Market Share Analysis, By Application                                        

                5.3 Therapeutic Area                                                     

                                5.3.1 Introduction                                           

                                5.3.2 Gastrointestinal diseases                                  

                                5.3.3 Neurological diseases                                         

                                5.3.4 Oncology                                 

                                5.3.5 Infectious Diseases                                             

                                5.3.6 Cardiovascular Diseases                                    

                                5.3.7 Haematological diseases                                   

                                5.3.8 Inflammatory Diseases                                      

                                5.3.9 Y-o-Y Growth Analysis, By Therapeutic Area                                            

                                5.3.10  Market Attractiveness Analysis, By Therapeutic Area                                       

                                5.3.11  Market Share Analysis, By Therapeutic Area                                         

6. Geographical Analysis                                                                              

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                                6.1.3.1 By Geographical Area                     

                                                6.1.3.2 By Product Type                

                                                6.1.3.3 By Application                    

                                                6.1.3.4 By Therapeutic Area                        

                                6.1.4  Market Attractiveness Analysis                                     

                                                6.1.4.1 By Geographical Area                     

                                                6.1.4.2 By Product Type                

                                                6.1.4.3 By Application                    

                                                6.1.4.4 By Therapeutic Area                        

                                6.1.5  Market Share Analysis                                      

                                                6.1.5.1 By Geographical Area                     

                                                6.1.5.2 By Product Type                

                                                6.1.5.3 By Application                    

                                                6.1.5.4 By Therapeutic Area                        

                6.2 China                                                             

                6.3 India                                                              

                6.4 Japan                                                            

                6.5 South Korea                                                               

                6.6 Australia                                                      

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Ashland                                                        

                                8.1.1 Overview                                 

                                8.1.2 Product Type Analysis                                        

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 BASF SE                                                        

                8.3 FMC Corporation                                                     

                8.4 JRS Pharma                                                 

                8.5 DFE Pharma                                                

                8.6 Roquette                                                     

                8.7 The Dow Chemical Company                                                              

                8.8 Asahi Kasei Corporation                                                        

                8.9 Nippon Soda Co.                                                      

                8.10 Huber Corporation                                                

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia Pacific Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  2. Asia Pacific Natural Superdisintegrants Market By Region, From 2016-2021 ( USD Million )
  3. Asia Pacific Synthetic Superdisintegrants Market By Region, From 2016-2021 ( USD Million )
  4. Asia Pacific Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  5. Asia Pacific Capsules Market By Region, From 2016-2021 ( USD Million )
  6. Asia Pacific Tablets Market By Region, From 2016-2021 ( USD Million )
  7. Asia Pacific Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  8. Asia Pacific Gastrointestinal Diseases Market By Region, From 2016-2021 ( USD Million )
  9. Asia Pacific Neurological Diseases Market By Region, From 2016-2021 ( USD Million )
  10. Asia Pacific Oncology Market By Region, From 2016-2021 ( USD Million )
  11. Asia Pacific Infectious Diseases Market By Region, From 2016-2021 ( USD Million )
  12. Asia Pacific Cardiovascular Diseases Market By Region, From 2016-2021 ( USD Million )
  13. Asia Pacific Haematological Diseases Market By Region, From 2016-2021 ( USD Million )
  14. Asia Pacific Inflammatory Diseases Market By Region, From 2016-2021 ( USD Million )
  15. Japan Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  16. Japan Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  17. Japan Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  18. China Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  19. China Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  20. China Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  21. India Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  22. India Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  23. India Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  24. Australia Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  25. Australia Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  26. Australia Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  27. South Korea Superdisintegrants Market By Product Type, From 2016-2021 ( USD Million )
  28. South Korea Superdisintegrants Market By Application, From 2016-2021 ( USD Million )
  29. South Korea Superdisintegrants Market By Therapeutic Area, From 2016-2021 ( USD Million )
  30. Asia Pacific Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
  31. Asia Pacific Modified Starch Market By Region, From 2016-2021 ( USD Million )
  32. Asia Pacific Crospovidone Market By Region, From 2016-2021 ( USD Million )
  33. Asia Pacific Modified Cellulose Market By Region, From 2016-2021 ( USD Million )
  34. Asia Pacific Ion Exchange Resins Market By Region, From 2016-2021 ( USD Million )
  35. Asia Pacific Calcium Silicates Market By Region, From 2016-2021 ( USD Million )
  36. Japan Superdisintegrants Market By Synthetic superdisintegrants, From 2016-2021 ( USD Million )
  37. China Superdisintegrants Market By Synthetic superdisintegrants, From 2016-2021 ( USD Million )
  38. India Superdisintegrants Market By Synthetic superdisintegrants, From 2016-2021 ( USD Million )
  39. Australia Superdisintegrants Market By Synthetic superdisintegrants, From 2016-2021 ( USD Million )
  40. Asia Pacific Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
  41. Asia Pacific Modified Starch Market By Region, From 2016-2021 ( USD Million )
  42. Asia Pacific Crospovidone Market By Region, From 2016-2021 ( USD Million )
  43. Asia Pacific Modified Cellulose Market By Region, From 2016-2021 ( USD Million )
  44. Asia Pacific Ion Exchange Resins Market By Region, From 2016-2021 ( USD Million )
  45. Asia Pacific Calcium Silicates Market By Region, From 2016-2021 ( USD Million )
  46. Japan Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
  47. China Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
  48. India Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
  49. Australia Superdisintegrants Market By Synthetic Superdisintegrants, From 2016-2021 ( USD Million )
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.